Literature DB >> 12387709

Nuclear receptors: nomenclature, ligands, mechanisms of their effects on gene expression.

A N Smirnov1.   

Abstract

Nuclear receptors are DNA binding transcription factors possessing conservative domain organization. Their activity is regulated by lipophilic ligands, phosphorylation, and by interactions with other proteins. This review highlights the nomenclature of 1999 for human nuclear receptors and the ligand structure and domain organization of these receptors. The review also summarizes recent data on the structure of hormone response elements of specific genes, the structure-functional organization of receptor co-regulators (coactivators and corepressors). They mediate their effects on transcription via two main mechanisms: chromatin remodeling and the effect on the main transcriptional factors. Some attention is focused on specific features of signal transduction at negative hormone-response elements, regulation of receptor activity via phosphorylation, mechanisms of receptor cycle termination, and on physiological and biochemical properties of certain groups of receptors and processes that they regulate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387709     DOI: 10.1023/a:1020545200302

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  11 in total

1.  Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?

Authors:  Sevki Cetinkalp; Ilgın Yildirim Simsir; Fahri Sahin; Guray Saydam; Ali Ugur Ural; Candeger Yilmaz
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

2.  Peroxisome Proliferator-Activated Receptor α Protects Renal Tubular Cells from Gentamicin-Induced Apoptosis via Upregulating Na+/H+ Exchanger NHE1.

Authors:  Cheng-Hsien Chen; Tso-Hsiao Chen; Mei-Yi Wu; Jia-Rung Chen; Li-Yu Hong; Cai-Mei Zheng; I-Jen Chiu; Yuh-Feng Lin; Yung-Ho Hsu
Journal:  Mol Med       Date:  2015-11-23       Impact factor: 6.354

3.  Poly(ADP-ribose) polymerase 1 is a key regulator of estrogen receptor α-dependent gene transcription.

Authors:  Fengxiao Zhang; Yan Wang; Lin Wang; Xi Luo; Kun Huang; Cheng Wang; Meng Du; Fangmei Liu; Ting Luo; Dan Huang; Kai Huang
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

4.  Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.

Authors:  Shenyang Li; Kiran K Nagothu; Varsha Desai; Taewon Lee; William Branham; Carrie Moland; Judit K Megyesi; Mark D Crew; Didier Portilla
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

Review 5.  Immune mechanisms and novel pharmacological therapies of acute kidney injury.

Authors:  Amandeep Bajwa; Gilbert R Kinsey; Mark D Okusa
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

6.  Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.

Authors:  Eric Boitier; Jean-Charles Gautier; Ruth Roberts
Journal:  Comp Hepatol       Date:  2003-01-31

Review 7.  Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.

Authors:  Ana Maria Olivares; Oscar Andrés Moreno-Ramos; Neena B Haider
Journal:  J Exp Neurosci       Date:  2016-05-05

Review 8.  Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Front Immunol       Date:  2021-04-13       Impact factor: 7.561

Review 9.  Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway.

Authors:  Alexandre Vallée
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

Review 10.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.